MedTrace Logo

Treatment of Striae Distensae With Fractional Radiofrequency and Topical Tretinoin

NCT05461755 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-08-14

No results posted yet for this study

Summary

The study aims to explore the potential of combination therapy with fractional radiofrequency and topical tretinoin for treatment and overall improvement of striae albae. We also aim to assess subject satisfaction, local skin responses and adverse effects/reactions in relation to the treatments, alone and in combination.

Conditions

  • Striae Distensae

Interventions

COMBINATION_PRODUCT

Fractional radiofrequency and topical Tretinoin

Treatment of striae with fractional radiofrequency and topical tretinoin in combination

DRUG

Topical Tretinoin

Treatment of striae with topical tretinoin alone

DEVICE

Fractional radiofrequency

Treatment of striae with fractional radiofrequency alone

Sponsors & Collaborators

  • Merete Haedersdal

    lead OTHER

Principal Investigators

  • Merete Haedersdal, MD PhD DMSc · Bispebjerg Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-22
Primary Completion
2023-07-05
Completion
2023-07-05

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05461755 on ClinicalTrials.gov